Ring finger protein ZIN interacts with human immunodeficiency virus type 1 Vif

被引:17
作者
Feng, F
Davis, A
Lake, JA
Carr, J
Xia, W
Burrell, C
Li, P
机构
[1] Australian Ctr Hepatitis & HIV Virol Res, Infect Dis Labs, Inst Med & Vet Sci, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Sch Mol Biosci, Adelaide, SA, Australia
关键词
D O I
10.1128/JVI.78.19.10574-10581.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Virion infectivity factor (Vif) protein of human immunodeficiency virus type 1 (HIV-1) is essential for the productive infection of primary human CD4 T lymphocytes and macrophages. Vif overcomes the HIV-inhibitory effects of cellular factor APOBEC3G, which has cytidine deaminase activity. We previously reported the isolation of a Vif-interacting ring finger protein, Triad 3, from a human leukocyte cDNA library, using the yeast two-hybrid system. The full-length cellular protein homologue of Triad 3 has been recently identified as the zinc finger protein inhibiting NF-kappaB (ZIN). Sequence analysis indicates that Triad 3 protein contains all four major ring-like motifs of ZIN. We report here that ZIN binds to purified Vif in vitro and that Triad 3/ZIN interacts with HIV-1 Vif in transfected human 293T cells, as demonstrated by coimmunoprecipitation. To test the biological relevance of this interaction, we produced infectious HIV-1 NL4.3 in the presence or absence of cotransfected ZIN. HIV-1 NL4.3 virus stocks produced in the presence of exogenously expressed ZIN were twofold less infectious in a single-cycle infectivity assay than virus produced in the absence of exogenous ZIN. It was further shown that cells infected with HIV-1 NL4.3 virus stocks produced in the presence of exogenously expressed ZIN were impaired in viral DNA synthesis by twofold. The impairment in viral reverse transcription and the reduction in single-cycle viral infectivity were both shown to be dependent on the presence of Vif in the virus producer cells. The possible mechanisms by which ZIN interferes with the early events of HIV-1 replication are discussed.
引用
收藏
页码:10574 / 10581
页数:8
相关论文
共 45 条
  • [1] High level expression of human immunodeficiency virus type-1 Vif inhibits viral infectivity by modulating proteolytic processing of the gag precursor at the p2/nucleocapsid processing site
    Akari, H
    Fujita, M
    Kao, S
    Khan, MA
    Shehu-Xhilaga, M
    Adachi, A
    Strebel, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 12355 - 12362
  • [2] TRANSCOMPLEMENTATION OF VIF- HIV-1 MUTANTS IN CEM CELLS SUGGESTS THAT VIF AFFECTS LATE STEPS OF THE VIRAL LIFE-CYCLE
    BLANC, D
    PATIENCE, C
    SCHULZ, TF
    WEISS, R
    SPIRE, B
    [J]. VIROLOGY, 1993, 193 (01) : 186 - 192
  • [3] Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes
    Carr, JM
    Hocking, H
    Li, P
    Burrell, CJ
    [J]. VIROLOGY, 1999, 265 (02) : 319 - 329
  • [4] Feline immunodeficiency virus Vif localizes to the nucleus
    Chatterji, U
    Grant, CK
    Elder, JH
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (06) : 2533 - 2540
  • [5] A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-κB activation
    Chen, DY
    Li, XY
    Zhai, ZH
    Shu, HB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) : 15985 - 15991
  • [6] PERIPHERAL-BLOOD MONONUCLEAR-CELLS PRODUCE NORMAL AMOUNTS OF DEFECTIVE VIF(-) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES WHICH ARE RESTRICTED FOR THE PRERETROTRANSCRIPTION STEPS
    COURCOUL, M
    PATIENCE, C
    REY, F
    BLANC, D
    HARMACHE, A
    SIRE, J
    VIGNE, R
    SPIRE, B
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2068 - 2074
  • [7] Association of human immunodeficiency virus type 1 vif with RNA and its role in reverse transcription
    Dettenhofer, M
    Cen, S
    Carlson, BA
    Kleiman, L
    Yu, XF
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (19) : 8938 - 8945
  • [8] ROLE OF VIF IN REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CD4+ T LYMPHOCYTES
    GABUZDA, DH
    LAWRENCE, K
    LANGHOFF, E
    TERWILLIGER, E
    DORFMAN, T
    HASELTINE, WA
    SODROSKI, J
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (11) : 6489 - 6495
  • [9] REV ACTIVATES EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF-GENE AND VPR-GENE PRODUCTS
    GARRETT, ED
    TILEY, LS
    CULLEN, BR
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (03) : 1653 - 1657
  • [10] BIOLOGICAL-ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF REQUIRES MEMBRANE TARGETING BY C-TERMINAL BASIC DOMAINS
    GONCALVES, J
    SHI, B
    YANG, XY
    GABUZDA, D
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (11) : 7196 - 7204